Go Pro

Bryn Mawr Trust Advisors LLC Buys Shares of 5,875 The Allstate Corporation $ALL

Allstate logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • Bryn Mawr Trust Advisors initiated a position in Allstate by purchasing 5,875 shares valued at approximately $1.4 million. Institutional investors collectively own 76.47% of the insurer.
  • Allstate reported a strong quarter, with EPS of $8.99 versus the $6.06 consensus estimate and revenue up 11.8% year over year to $15.43 billion. The company also declared a quarterly dividend of $1.08 per share, representing a 1.7% yield.
  • Analyst views remain mixed: JPMorgan raised its price target to $292, while Citigroup and Wells Fargo downgraded the stock; the consensus rating is Hold with an average target of $265.53. Recent substantial insider selling and valuation concerns add caution despite the earnings beat.
  • Interested in Allstate? Here are five stocks we like better.

Bryn Mawr Trust Advisors LLC purchased a new stake in The Allstate Corporation (NYSE:ALL - Free Report) during the second quarter, according to its most recent filing with the SEC. The firm purchased 5,875 shares of the insurance provider's stock, valued at approximately $1,398,000.

Other large investors have also recently made changes to their positions in the company. State Street Corp grew its stake in Allstate by 3.7% in the fourth quarter. State Street Corp now owns 12,297,551 shares of the insurance provider's stock valued at $2,571,600,000 after purchasing an additional 438,034 shares during the last quarter. Bank of America Corp DE lifted its position in shares of Allstate by 8.1% during the first quarter. Bank of America Corp DE now owns 7,913,320 shares of the insurance provider's stock valued at $1,640,748,000 after buying an additional 596,321 shares during the last quarter. GQG Partners LLC lifted its position in shares of Allstate by 36.0% during the fourth quarter. GQG Partners LLC now owns 5,488,560 shares of the insurance provider's stock valued at $1,142,449,000 after buying an additional 1,452,993 shares during the last quarter. Franklin Resources Inc. boosted its holdings in shares of Allstate by 29.2% in the 4th quarter. Franklin Resources Inc. now owns 5,007,549 shares of the insurance provider's stock valued at $1,042,321,000 after buying an additional 1,131,172 shares in the last quarter. Finally, Boston Partners boosted its holdings in shares of Allstate by 14.9% in the 3rd quarter. Boston Partners now owns 3,050,780 shares of the insurance provider's stock valued at $654,652,000 after buying an additional 395,195 shares in the last quarter. 76.47% of the stock is owned by institutional investors.

Insider Transactions at Allstate

In related news, insider Mark Q. Prindiville sold 1,550 shares of the company's stock in a transaction that occurred on Friday, May 22nd. The stock was sold at an average price of $216.27, for a total value of $335,218.50. Following the sale, the insider owned 27,558 shares in the company, valued at $5,959,968.66. This represents a 5.32% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider John E. Dugenske sold 32,996 shares of the stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of $269.33, for a total transaction of $8,886,812.68. Following the completion of the transaction, the insider owned 13,054 shares in the company, valued at approximately $3,515,833.82. This trade represents a 71.65% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 92,996 shares of company stock worth $24,543,894. 1.55% of the stock is owned by company insiders.

Allstate Price Performance

NYSE ALL opened at $261.26 on Friday. The company has a debt-to-equity ratio of 0.24, a current ratio of 0.36 and a quick ratio of 0.36. The stock's fifty day moving average price is $246.52 and its 200 day moving average price is $222.83. The Allstate Corporation has a 1 year low of $188.08 and a 1 year high of $277.22. The company has a market cap of $66.06 billion, a price-to-earnings ratio of 5.22, a PEG ratio of 0.40 and a beta of 0.16.

Allstate (NYSE:ALL - Get Free Report) last issued its quarterly earnings results on Wednesday, August 5th. The insurance provider reported $8.99 EPS for the quarter, topping analysts' consensus estimates of $6.06 by $2.93. The company had revenue of $15.43 billion during the quarter, compared to analysts' expectations of $15.46 billion. Allstate had a return on equity of 41.64% and a net margin of 18.97%.The firm's revenue was up 11.8% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $5.94 EPS. As a group, equities research analysts forecast that The Allstate Corporation will post 33.92 earnings per share for the current year.

Allstate Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, October 1st. Investors of record on Monday, August 31st will be issued a dividend of $1.08 per share. The ex-dividend date of this dividend is Monday, August 31st. This represents a $4.32 dividend on an annualized basis and a dividend yield of 1.7%. Allstate's payout ratio is 8.63%.

Wall Street Analyst Weigh In

Several research analysts recently commented on ALL shares. Wall Street Zen upgraded shares of Allstate from a "hold" rating to a "buy" rating in a research note on Monday, July 20th. Citigroup downgraded shares of Allstate from a "neutral" rating to a "sell" rating and raised their target price for the company from $226.00 to $240.00 in a research note on Tuesday. The Goldman Sachs Group reaffirmed a "neutral" rating and issued a $280.00 price target on shares of Allstate in a report on Friday, August 7th. Wells Fargo & Company downgraded Allstate from an "equal weight" rating to an "underweight" rating and upped their price target for the stock from $243.00 to $250.00 in a research report on Friday, August 7th. Finally, JPMorgan Chase & Co. increased their price objective on Allstate from $282.00 to $292.00 and gave the company an "overweight" rating in a report on Tuesday. Three research analysts have rated the stock with a Strong Buy rating, five have assigned a Buy rating, ten have issued a Hold rating and three have issued a Sell rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Hold" and an average target price of $265.53.

Check Out Our Latest Stock Analysis on ALL

More Allstate News

Here are the key news stories impacting Allstate this week:

  • Positive Sentiment: Analyst earnings estimates were raised. Dowling & Partners increased its FY2026 EPS estimate for Allstate to $35.50 from $30.50, reinforcing expectations for continued profitability. FY2026 EPS estimates article
  • Positive Sentiment: JPMorgan reportedly expects further upside. The analyst maintained an overweight rating and raised its price target to $292 from $282, supporting the bullish case following Allstate’s recent earnings beat. JPMorgan analyst article
  • Positive Sentiment: Allstate is investing in quantum computing. CEO Tom Wilson said the insurer plans to expand its current 10-person quantum team so it can build expertise and potentially gain a competitive advantage as the technology matures. The investment is strategically positive, although financial benefits are likely long term. Allstate quantum computing article
  • Positive Sentiment: Claims operations are receiving additional investment. Allstate opened a 33,000-square-foot training campus in Dallas for its 23,000 claims professionals. Improved claims accuracy and customer service could support retention and operating efficiency. Allstate Claims University announcement
  • Neutral Sentiment: Recent earnings remain a major backdrop. Allstate’s latest quarter produced $8.99 in EPS versus the $6.06 consensus estimate, while revenue rose 11.8% year over year to $15.43 billion. However, the stock is trading near its 52-week high, increasing sensitivity to any signs that profitability may moderate.
  • Negative Sentiment: Insiders sold substantial holdings. COO Mario Rizzo sold 56,225 shares for approximately $14.9 million, reducing his direct position by 40.6%. Separate reports also disclosed a sizable sale by John Dugenske, potentially weighing on investor sentiment. Allstate insider sales article
  • Negative Sentiment: Allstate lost an Ontario coverage challenge. Definity prevailed in court over Allstate’s excluded-driver coverage position, creating a potential legal and claims-related concern in the Canadian market. Ontario court coverage challenge article
  • Negative Sentiment: Valuation concerns remain. One analysis argues Allstate’s share price assumes a 94.1% combined ratio that the company has never sustained, raising questions about whether its recent operating returns can persist.

Allstate Company Profile

(Free Report)

Allstate Corporation is a publicly traded insurance company headquartered in Northbrook, Illinois, and is one of the largest personal lines property and casualty insurers in the United States. Founded in 1931 as a subsidiary of Sears, Roebuck and Co, Allstate has grown into a diversified insurer that serves millions of consumers and businesses through a mix of distribution channels and product offerings.

The company underwrites a broad range of insurance products, with primary emphasis on auto and homeowners coverage.

Further Reading

Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Corporation (NYSE:ALL - Free Report).

Institutional Ownership by Quarter for Allstate (NYSE:ALL)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Allstate Right Now?

Before you consider Allstate, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.

While Allstate currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines